Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) Revenue: 2024

Historic Revenue for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $131.2 million.

  • Day One Biopharmaceuticals' Revenue fell 57.56% to $39.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.7 million, marking a year-over-year change of. This contributed to the annual value of $131.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Revenue of $131.2 million as of FY2024.
  • Day One Biopharmaceuticals' 5-year Revenue high stood at $131.2 million for FY2024, and its period low was $131.2 million during FY2024.
  • Its 1-year average for Revenue is $131.2 million, with a median of $131.2 million in 2024.